PEGAVISION CORPORATION Pegavision Corporation Share Price
Equities
6491
TW0006491004
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 514 TWD | -1.15% |
|
+12.97% | +29.63% |
| Sales 2024 * | 7.88B 242M 20.16B | Sales 2025 * | 8.73B 268M 22.35B | Capitalization | 40.09B 1.23B 103B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.02B 62.1M 5.18B | Net income 2025 * | 2.33B 71.64M 5.97B | EV / Sales 2024 * | 4.65 x |
| Net cash position 2024 * | 3.49B 107M 8.92B | Net cash position 2025 * | 6.73B 206M 17.21B | EV / Sales 2025 * | 3.82 x |
| P/E ratio 2024 * |
19.8
x | P/E ratio 2025 * |
17.2
x | Employees | - |
| Yield 2024 * |
2.32% | Yield 2025 * |
2.65% | Free-Float | 52.23% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.15% | ||
| 1 week | +12.97% | ||
| Current month | +13.22% | ||
| 1 month | +14.48% | ||
| 3 months | +37.80% | ||
| 6 months | +32.65% | ||
| Current year | +29.63% |
1 week
446.50
530.00
1 month
444.50530.00
Current year
368.00530.00
1 year
328.00530.00
3 years
270.50678.00
5 years
81.50678.00
10 years
63.71678.00
| Managers | Title | Age | Since |
|---|---|---|---|
Te Sheng Yang
CEO | Chief Executive Officer | - | 14/18/14 |
| Director of Finance/CFO | - | 27/13/27 | |
Danny Peng
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tzu Hsien Tung
BRD | Director/Board Member | 63 | 12/09/12 |
Te Sheng Yang
CEO | Chief Executive Officer | - | 14/18/14 |
Ming Tung Kuo
CHM | Chairman | - | 12/09/12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 514 | -1.15% | 911,911 |
| 25/24/25 | 520 | +6.67% | 2,301,710 |
| 24/24/24 | 487.5 | +1.04% | 760,150 |
| 23/24/23 | 482.5 | +5.35% | 983,457 |
| 22/24/22 | 458 | +0.66% | 585,362 |
End-of-day quote Taiwan S.E., April 26, 2024
More quotes
Pegavision Corp is primarily engaged in the manufacture and sale of private brand contact lenses, as well as the original equipment manufacturing (OEM) business. The Company distributes its products within domestic market and to overseas markets.
Calendar
06/05/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
514
TWD
Average target price
474.8
TWD
Spread / Average Target
-7.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.63% | 1.23B | |
| +11.95% | 98.12B | |
| +9.69% | 38.82B | |
| -6.10% | 17.66B | |
| -20.02% | 2.24B | |
| -8.37% | 1.54B | |
| -35.62% | 747M | |
| -35.36% | 735M | |
| -13.36% | 623M | |
| +24.04% | 494M |
- Stock Market
- Equities
- 6491 Stock
